January 2026
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
DayOne Accelerator relaunches to bridge healthtech innovation gap with pharma industry
, /in E-News /by panglobalThe equity-free accelerator programme, based in Basel’s life sciences hub, aims to address the 80% failure rate of healthtech startups by providing direct access to pharmaceutical expertise and resources.
German clinical diagnostics leader partners with US genomics innovator to advance cancer testing
, /in E-News /by panglobalCancer diagnostics in Germany is set to enter a new phase as Labor Dr. Wisplinghoff collaborates with US-based Genomic Testing Cooperative to implement advanced molecular testing capabilities, with RNA analysis at the forefront of this precision medicine initiative.
Navigo Proteins and SCK CEN join forces to advance targeted radiotheranostics
, /in E-News /by panglobalGerman biotechnology company Navigo Proteins has established a strategic research collaboration with SCK CEN, the Belgian Nuclear Research Centre, to accelerate development of targeted radiotheranostics. The partnership aims to combine Navigo’s expertise in precision carrier molecules with SCK CEN’s capabilities in radioisotope production and preclinical testing.
Wiley expands forensic capabilities with updated designer drugs database
, /in E-News, Therapeutic Drug Monitoring /by panglobalWiley has announced the release of its 2025 edition of the Mass Spectra of Designer Drugs database, a critical resource expanding forensic laboratories’ capabilities in the identification of illicit substances. The updated database represents a substantial advancement in analytical tools available to forensic scientists combating the proliferation of novel psychoactive substances.
Alarming rise in child deaths from antimicrobial resistance
, /in E-News /by panglobalNew research reveals over 3 million children died globally from AMR-related infections in 2022, with particular concerns about increasing use of critical antibiotic classes.
IL-6 biomarker breakthrough for early sepsis detection
Sepsis, /in E-News, Molecular Diagnostics /by panglobalNew research identifies interleukin-6 as a superior diagnostic biomarker for sepsis in high-risk populations including neonates, children, and pregnant women.
Pfizer halts development of oral GLP-1 agonist danuglipron
, /in E-News /by panglobalSafety concerns prompt Pfizer to terminate development of once-daily oral GLP-1 receptor agonist for weight management, despite promising pharmacokinetic data from recent dose-optimisation studies.
Basel-based equity-free DayOne Accelerator opens for healthtech startups
, /in E-News /by panglobalBasel’s equity-free pharma-focused accelerator programme returns to bridge the gap between healthtech innovations and pharmaceutical R&D needs.
Bruker expands infectious disease diagnostics portfolio at ESCMID 2025
, /in Product News /by panglobalBruker Corporation has announced significant expansions to its infectious disease testing solutions at the ESCMID Global conference in Vienna, including a broader assay menu for its BeGenius® molecular diagnostics system and improvements to its microbial identification platforms.
Beckman Coulter introduces next-gen basophil activation test for allergy research
, /in E-News /by panglobalBeckman Coulter Life Sciences has launched a ground-breaking Next-Generation Basophil Activation Test (BAT) that could transform food allergy research by eliminating the need for potentially dangerous allergen exposure.